Literature DB >> 27073176

Partners in the Warburg effect.

Joshua D Rabinowitz1, Hilary A Coller2,3.   

Abstract

Cells that surround tumors produce vesicles that supply nutrients to cancer cells and, more surprisingly, also impair the generation of energy in these cancer cells.

Entities:  

Keywords:  cancer metabolism; cell biology; exosomes; human; human biology; macropinocytosis; medicine; metabolic flux analysis; reductive carboxylation; tumor microenvironment

Mesh:

Year:  2016        PMID: 27073176      PMCID: PMC4841767          DOI: 10.7554/eLife.15938

Source DB:  PubMed          Journal:  Elife        ISSN: 2050-084X            Impact factor:   8.140


Related research article Zhao H, Yang L, Baddour J, Achreja A, Bernard V, Moss T, Marini JC, Tudawe T, Seviour EG, San Lucas FA, Alvarez H, Gupta S, Maiti SN, Cooper L, Peehl D, Ram PT, Maitra A, Nagrath D. 2016. Tumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism. eLife 5:e10250. doi: 10.7554/eLife.10250 Image Cancer cells (pale blue) receive vesicles (dark blue) from neighboring cells (yellow) In 1918 Albert Einstein convinced Otto Warburg to leave the German infantry and fulfill his patriotic requirements in the first World War by performing research instead (Koppenol et al., 2011). Back in the lab at the Kaiser Wilhelm Institute, Warburg discovered that thin slices of tumors produced lactate much more rapidly than normal tissue. This rapid fermentation of glucose by tumors, even in the presence of ample oxygen, was the first biochemical trait assigned to cancer and is known as the Warburg effect. When oxygen is present, most human cells rely on a process called oxidative phosphorylation inside mitochondria to convert lactate into carbon dioxide and usable energy. Warburg proposed that the rapid glucose fermentation and associated lactate secretion by the cancer cells was due to mitochondrial dysfunction. However, subsequent studies have shown that most cancer cells do have working mitochondria and, moreover, depend heavily upon them to produce energy (Zu and Guppy, 2004; Moreno-Sánchez et al., 2007). Instead of causing mitochondrial dysfunction, it was found that the mutations that cause cancer also promote the breakdown of glucose in a process called glycolysis. The most striking example involves the PI3K-Akt signaling pathway, which both transduces the signal from the hormone insulin to drive glucose uptake, and is one of the most frequently mutated pathways in cancer. One way this pathway can be activated is by the loss of a tumor suppressing enzyme called PTEN (Shaw and Cantley, 2006). The observation of oncogene-driven glucose uptake seemed to neatly explain the Warburg effect. Over the past few decades, evidence has steadily accumulated that cancer cells also hijack surrounding cells (Cirri and Chiarugi, 2012). For example, cancer cells secrete growth factors to promote the formation of new blood vessels (Orimo et al., 2005), which are required to supply tumors with nutrients. Moreover, they co-opt surrounding connective tissue cells, including fibroblasts, which exchange signals with the cancer cells in a manner that ultimately drives tumor growth and likely helps to suppress immune responses to the tumor (Cirri and Chiarugi, 2012). However, both the mechanism of this exchange and its role in tumor growth remain poorly understood. Fibroblasts may exchange both signaling molecules and metabolic fuels with the cancer cells, either by secreting individual molecules (e.g. lactate; Martinez-Outschoorn et al., 2014) or by releasing membrane-bound vesicles known as exosomes (Castellana et al., 2009). For example, recent work has shown that the spread of cancer in the brain is promoted by the exosomes that are released by a particular type of brain cell. These exosomes contain small RNA molecules known as microRNAs that can silence the gene that encodes the PTEN enzyme, whose loss drives an increase in glycolysis (Zhang et al., 2015). Now, in eLife, Deepak Nagrath at Rice University and colleagues – including Hongyun Zhao as first author – show that cancer-associated fibroblasts release exosomes that both deliver nutrients to cancer cells and inhibit oxidative phosphorylation (Zhao et al., 2016; Figure 1). Zhao et al. use isotope-labelled carbon compounds to provide compelling evidence that exosomes from fibroblasts can supply an amino acid called glutamine and other nutrients to cancer cells. A shortage of glutamine can limit the growth of pancreatic and perhaps other cancers (Kamphorst et al., 2015). Importantly, although the exosomes contribute modest amounts of nutrients, they can protect cancer cells from starvation, hinting at one potential role for such metabolic exchange in tumors. More striking and surprising is the role of the exosomes in causing the Warburg effect. Adding exosomes to prostate or pancreatic cancer cells both promotes glycolysis and blocks oxidative metabolism. It is likely that the increase in glycolysis is caused by the reduction in oxidative phosphorylation so, in this respect, the exosomes trigger glycolysis in the way initially envisioned by Warburg. These results call for a re-examination of the contributions of both processes to energy generation in cancer cells that are still associated with their neighbors. Such re-examination is particularly important given that oxidative phosphorylation is reduced so dramatically in cancer cells, with oxygen consumption lowered by up to 80% within 24 hours of receiving exosomes from fibroblasts. Zhao et al. – who are based at Rice University, Baylor College of Medicine, the University of Texas MD Anderson Cancer Center and Stanford University – propose that the exosomes may deliver microRNAs that silence oxidative metabolism genes, but this is hard to reconcile with the timing. Since the proteins involved in oxidative phosphorylation are generally long-lived, even complete inhibition of their production seems unlikely to produce such drastic effects so quickly. Nor can the decreased oxidative phosphorylation be explained by the delivery of nutrients by exosomes, because increasing the access to such nutrients would be expected to promote, not inhibit, the use of oxygen. Thus, understanding how the exosomes inhibit oxidative phosphorylation is a key challenge going forward. Such work holds the potential to illuminate not only the Warburg effect, but also the regulation of oxidative phosphorylation in cells more generally.

Fibroblasts supply nutrients to cancer cells and inhibit oxidative phosphorylation in cancer cells.

Fibroblasts (pink cells) associate with epithelial cancer cells (blue cells) and release exosomes (circles) that transfer nutrients to epithelial cancer cells (orange lines). In addition, they inhibit mitochondrial oxidative phosphorylation in the cancer cells (black blunt arrows), perhaps via microRNAs that silence particular genes.
  11 in total

Review 1.  Ras, PI(3)K and mTOR signalling controls tumour cell growth.

Authors:  Reuben J Shaw; Lewis C Cantley
Journal:  Nature       Date:  2006-05-25       Impact factor: 49.962

2.  Human pancreatic cancer tumors are nutrient poor and tumor cells actively scavenge extracellular protein.

Authors:  Jurre J Kamphorst; Michel Nofal; Cosimo Commisso; Sean R Hackett; Wenyun Lu; Elda Grabocka; Matthew G Vander Heiden; George Miller; Jeffrey A Drebin; Dafna Bar-Sagi; Craig B Thompson; Joshua D Rabinowitz
Journal:  Cancer Res       Date:  2015-02-01       Impact factor: 12.701

3.  Tumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism.

Authors:  Hongyun Zhao; Lifeng Yang; Joelle Baddour; Abhinav Achreja; Vincent Bernard; Tyler Moss; Juan C Marini; Thavisha Tudawe; Elena G Seviour; F Anthony San Lucas; Hector Alvarez; Sonal Gupta; Sourindra N Maiti; Laurence Cooper; Donna Peehl; Prahlad T Ram; Anirban Maitra; Deepak Nagrath
Journal:  Elife       Date:  2016-02-27       Impact factor: 8.140

4.  Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth.

Authors:  Lin Zhang; Siyuan Zhang; Jun Yao; Frank J Lowery; Qingling Zhang; Wen-Chien Huang; Ping Li; Min Li; Xiao Wang; Chenyu Zhang; Hai Wang; Kenneth Ellis; Mujeeburahiman Cheerathodi; Joseph H McCarty; Diane Palmieri; Jodi Saunus; Sunil Lakhani; Suyun Huang; Aysegul A Sahin; Kenneth D Aldape; Patricia S Steeg; Dihua Yu
Journal:  Nature       Date:  2015-10-19       Impact factor: 49.962

Review 5.  Cancer-associated-fibroblasts and tumour cells: a diabolic liaison driving cancer progression.

Authors:  Paolo Cirri; Paola Chiarugi
Journal:  Cancer Metastasis Rev       Date:  2012-06       Impact factor: 9.264

6.  Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion.

Authors:  Akira Orimo; Piyush B Gupta; Dennis C Sgroi; Fernando Arenzana-Seisdedos; Thierry Delaunay; Rizwan Naeem; Vincent J Carey; Andrea L Richardson; Robert A Weinberg
Journal:  Cell       Date:  2005-05-06       Impact factor: 41.582

Review 7.  Catabolic cancer-associated fibroblasts transfer energy and biomass to anabolic cancer cells, fueling tumor growth.

Authors:  Ubaldo E Martinez-Outschoorn; Michael P Lisanti; Federica Sotgia
Journal:  Semin Cancer Biol       Date:  2014-01-28       Impact factor: 15.707

Review 8.  Energy metabolism in tumor cells.

Authors:  Rafael Moreno-Sánchez; Sara Rodríguez-Enríquez; Alvaro Marín-Hernández; Emma Saavedra
Journal:  FEBS J       Date:  2007-03       Impact factor: 5.542

9.  Membrane microvesicles as actors in the establishment of a favorable prostatic tumoral niche: a role for activated fibroblasts and CX3CL1-CX3CR1 axis.

Authors:  Donatello Castellana; Fatiha Zobairi; Maria Carmen Martinez; Maria Antonietta Panaro; Vincenzo Mitolo; Jean-Marie Freyssinet; Corinne Kunzelmann
Journal:  Cancer Res       Date:  2009-01-20       Impact factor: 12.701

Review 10.  Cancer metabolism: facts, fantasy, and fiction.

Authors:  Xin Lin Zu; Michael Guppy
Journal:  Biochem Biophys Res Commun       Date:  2004-01-16       Impact factor: 3.575

View more
  5 in total

Review 1.  Ceramide and Exosomes: A Novel Target in Cancer Biology and Therapy.

Authors:  Ahmed Elsherbini; Erhard Bieberich
Journal:  Adv Cancer Res       Date:  2018-06-09       Impact factor: 6.242

Review 2.  The key role of extracellular vesicles in the metastatic process.

Authors:  Hongyun Zhao; Abhinav Achreja; Elisabetta Iessi; Mariantonia Logozzi; Davide Mizzoni; Rossella Di Raimo; Deepak Nagrath; Stefano Fais
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2017-11-24       Impact factor: 10.680

Review 3.  Revisiting the Crabtree/Warburg effect in a dynamic perspective: a fitness advantage against sugar-induced cell death.

Authors:  Elisabetta de Alteriis; Fabrizio Cartenì; Palma Parascandola; Jacinta Serpa; Stefano Mazzoleni
Journal:  Cell Cycle       Date:  2018       Impact factor: 4.534

Review 4.  Sleeping Beauty and the Microenvironment Enchantment: Microenvironmental Regulation of the Proliferation-Quiescence Decision in Normal Tissues and in Cancer Development.

Authors:  Ana Paula Zen Petisco Fiore; Pedro de Freitas Ribeiro; Alexandre Bruni-Cardoso
Journal:  Front Cell Dev Biol       Date:  2018-06-07

Review 5.  Fatty Acids and Membrane Lipidomics in Oncology: A Cross-Road of Nutritional, Signaling and Metabolic Pathways.

Authors:  Carla Ferreri; Anna Sansone; Rosaria Ferreri; Javier Amézaga; Itziar Tueros
Journal:  Metabolites       Date:  2020-08-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.